載入...
Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema
Diabetic retinopathy (DR) is the most common cause of visual loss among working age individuals. Diabetic macular edema (DME) is an important complication of DR that affects around one third of the patients with DR. Several treatments have been approved for DME ranging from blood pressure and glycem...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Co., Limited
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3874490/ https://ncbi.nlm.nih.gov/pubmed/24379921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.303 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|